CONNIE WITT: Open Payments
NPI 1902804297 · TRION, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,358 in 77 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $615 · 2025 $1,358
Food & beverage: $1,358
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $335 |
| Boston Scientific Corporation | 5 | $290 |
| Novo Nordisk Inc | 7 | $241 |
| PFIZER INC. | 5 | $101 |
| Abbott Laboratories | 5 | $89 |
| Inspire Medical Systems, Inc. | 1 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Exact Sciences Corporation | 3 | $55 |
| Gilead Sciences, Inc. | 1 | $35 |
| Astellas Pharma US Inc | 2 | $29 |
Products named: VRAYLAR, WATCHMAN FLX, Wegovy, CDS - MCT/CEM Monitoring, FREESTYLE LIBRE 3, Ozempic, INSPIRE, UBRELVY.
Industry payments across GA — which companies pay providers there.
